Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-03

Clinical Trial Update: Lidocaine Infusion in Pancreatic Cancer [EARLY_Phase 1]

View source ↗

Summary

This entry reports an early Phase 1 clinical trial evaluating lidocaine infusion for pancreatic cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lidocaine (Lidocaine)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Pancreatic Cancer | EARLY_Phase 1 | Status: RECRUITING